Bedside pleuroscopy in Taiwan : a great vision for critically-ill patients and intensivists

Ooi, Hean

doi:10.7603/s40681-016-0013-5

Cited by 13 publications

(8 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…et al, 2016 ; Chen Y.F. et al, 2016 ; Hsieh et al, 2016 ; Hsu and Yin, 2016 ; Huang and Chang, 2016 ; Lin and Lin, 2016 ; Maa and Leu, 2016 ; Ooi, 2016 ; Yu et al, 2016 ). The Taiwan National Health Insurance Program began in March 1995, and now it has covered around 99% of the residents living in Taiwan ( National Health Insurance Research Database, 2017 ).…”

Section: Methodsmentioning

confidence: 99%

Use of Oral Corticosteroids and Risk of Hip Fracture in the Elderly in a Case-Control Study

2017

View full text Add to dashboard Cite

Aim: Little is known regarding the relationship between use of oral corticosteroids and hip fracture in the elderly in Taiwan. The aim of the study was to examine this issue.Methods: A retrospective population-based case-control study using the database of the Taiwan National Health Insurance Program (2000–2013) was conducted. We identified 4538 individuals aged ≥ 65 years with newly diagnosed hip fracture as the cases. We randomly selected 4538 individuals without hip fracture as the control subjects. The cases and the control subjects were matched with sex, age, comorbidities, and the year of index date. Individuals who never had a prescription for oral corticosteroids were defined as never use. Individuals who ever had at least one prescription for oral corticosteroids were defined as ever use. The odds ratio (OR) and 95% confidence interval (CI) of hip fracture associated with oral corticosteroids use was estimated by a multivariable unconditional logistic regression analysis.Results: After adjustments for potential confounding factors, the multivariable logistic regression model showed that the adjusted OR of hip fracture was 1.17 for individuals with ever use of oral corticosteroids (95%CI 1.08, 1.28), compared to those with never use of oral corticosteroids. An sub-analysis showed that for every 1-mg increase in cumulative dose of oral corticosteroids, the adjusted OR of hip fracture was 1.01 (95% CI 1.01, 1.02). The adjusted ORs were 1.31 (95% CI 1.17, 1.47) for cumulative exposure to oral corticosteroids ≥ 3 months and 1.09 (95% CI 0.98, 1.20) for cumulative exposure < 3 months.Conclusion: We conclude that oral corticosteroids use is associated with a trivial but statistically significant increase in risk of hip fracture in Taiwan. Additionally, the results suggest that there are dose-response and duration-response effects of oral corticosteroids on the risk of hip fracture. The results confirm our understanding of oral corticosteroid-associated hip fracture in the elderly.

show abstract

Section: Methodsmentioning

confidence: 99%

Use of Oral Corticosteroids and Risk of Hip Fracture in the Elderly in a Case-Control Study

2017

View full text Add to dashboard Cite

show abstract

“…Taiwan is an independent country with more than 23 million people ( Huang and Chang, 2016 ; Maa and Leu, 2016 ; Ooi, 2016 ; Yu et al, 2016 ; Chen et al, 2017 ; Lee et al, 2017 ). We conducted a retrospective nationwide case-control study to analyze the database of the Taiwan National Health Insurance Program.…”

Section: Methodsmentioning

confidence: 99%

Nationwide Case-Control Study Examining the Association between Tamoxifen Use and Alzheimer’s Disease in Aged Women with Breast Cancer in Taiwan

2017

View full text Add to dashboard Cite

Background and Objectives: Little is known about the association between tamoxifen use and Alzheimer’s disease in women with breast cancer. The study aimed to explore the association between tamoxifen use and Alzheimer’s disease in aged women with breast cancer in Taiwan.Methods: We conducted a retrospective nationwide case-control study using the database of the Taiwan National Health Insurance Program. Totally, 173 female subjects with breast cancer aged ≥ 65 years with newly diagnosed Alzheimer’s disease from 2000 to 2011 were identified as the cases. Additionally, 684 female subjects with breast cancer aged ≥ 65 years without any type of dementia were selected as the matched controls. The cases and the matched controls were matched with age and comorbidities. Ever use of tamoxifen was defined as subjects who had at least a prescription for tamoxifen before the index date. Never use of tamoxifen was defined as subjects who never had a prescription for tamoxifen before the index date. We used the logistic regression model to calculate the odds ratio (OR) and 95% confidence interval (CI) of Alzheimer’s disease associated with tamoxifen use.Results: The OR of Alzheimer’s disease was 3.09 for subjects with ever use of tamoxifen (95% CI 2.10, 4.55), compared with never use. The OR of Alzheimer’s disease was 1.23 for subjects with increasing cumulative duration of tamoxifen use for every 1 year (95% CI 1.13, 1.34), compared with never use.Conclusion: The increased odds of Alzheimer’s disease associated with tamoxifen use may be due to the survival effect, not the toxic effect. That is, the longer the tamoxifen use, the longer the patients survive, and the greater the likelihood that she may have a chance to develop Alzheimer’s disease.

show abstract

“…Taiwan is an independent country with a population of over 23 million (Chao et al, 2015; Chen et al, 2015; Ho and Chang, 2015; Hsiao et al, 2015; Hung and Ku, 2015; Lin and Lin, 2016; Lin et al, 2016a; Maa and Leu, 2016; Ooi, 2016; Yu et al, 2016). We conducted a population-based case-control study using data from the Taiwan National Health Insurance Program.…”

Section: Methodsmentioning

confidence: 99%

Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan

et al. 2017

View full text Add to dashboard Cite

Background and Objectives: Although the relationship between the use of proton pump inhibitors (PPIs) and pulmonary tuberculosis (TB) in Taiwan published in 2014. Due to just only one article and not enough comprehensively, we explore this issue.Methods: We conducted a population-based case-control study to identify 9,422 subjects aged 20 years or older with newly diagnosed pulmonary TB in 2000–2013 as test cases. We then randomly selected 9,422 subjects aged 20 years or older without pulmonary TB as controls. Both cases and controls were matched in terms of sex, age, and comorbidities. Use of PPIs were defined as subjects who had had at least one prescription for these medications before the index date. No use was defined as subjects who had never had a prescription for PPIs before the index date. The odds ratio (OR) and 95% confidence interval (CI) for pulmonary TB associated with PPI use was estimated using the logistic regression model.Results: The OR of pulmonary TB was 1.31 for subjects who had used PPIs (95% CI 1.22, 1.41) compared with those with no use of the medications. Sub-analysis revealed the OR of pulmonary TB in subjects using PPI per increasing microgram was 1.25 (95% CI 1.19, 1.30).Conclusions: PPI use is associated with a 1.3-fold increase in odds of developing pulmonary TB in Taiwan. There is a dose-related response between PPI use and pulmonary TB.

show abstract

Bedside pleuroscopy in Taiwan : a great vision for critically-ill patients and intensivists

Cited by 13 publications

References 47 publications

Use of Oral Corticosteroids and Risk of Hip Fracture in the Elderly in a Case-Control Study

Use of Oral Corticosteroids and Risk of Hip Fracture in the Elderly in a Case-Control Study

Nationwide Case-Control Study Examining the Association between Tamoxifen Use and Alzheimer’s Disease in Aged Women with Breast Cancer in Taiwan

Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan

Contact Info

Product

Resources

About